Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open Label Clinical Study on the Efficacy of Tofacitinib in the Treatment of IgG4 Related Diseases

NCT07827469 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07827469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07827469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open Label Clinical Study on the Efficacy of Tofacitinib in the Treatment of IgG4 Related Diseases
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2023
Completion date
June 3, 2026
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunoglobulin g4-related disease, janus kinase inhibitors